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*Mycobacterium heraklionense* is an unpigmented member of the *Mycobacterium terrae* complex that was originally isolated from Heraklion, a city in Crete, Greece ([@B1]). It is an uncommon cause of infection of humans, with the first case reported only in 2014 ([@B2]). *Mycobacterium heraklionense* has also been reported to have been isolated from water treatment sludge ([@B3]). The notable phenotypic characteristics of *Mycobacterium heraklionense* include an intermediate growth rate, smooth colonies with no pigmentation, positive nitrate reduction, and positive beta-glucosidase activity ([@B1]).

Rapidly growing mycobacteria constitute a commonly isolated population of acid-fast bacilli in the clinical microbiology lab of varying clinical importance, and molecular methods are often the only means of rapidly discriminating between them ([@B4], [@B5]). We sequenced the first draft genome of *Mycobacterium heraklionense* from a fine-needle aspiration sample from a 53-year-old woman, who presented to an orthopedic surgery clinic in 2014 with a right-medial soft-tissue ankle mass. The patient had previously had a repair of a transverse laceration of her right Achilles tendon after a gardening accident 20 years prior. Cytological analysis of the aspirate revealed purulent fluid consistent with an inflamed cyst, and the acid-fast bacillus culture returned positive on day 14 of culture. The isolate was originally typed as *Mycobacterium heraklionense* based on partial *rpoB* sequencing. Susceptibility testing showed the following MICs (μg/mL): amikacin, ≤2; ciprofloxacin, \>4; clarithromycin, ≥4; ethambutol, 1.25; kanamycin, 8; moxifloxacin, \>2; rifabutin, 0.25; rifampin, \>16; and streptomycin, 4. No other bacteria or yeast were recovered from the aspirate.

DNA from *M. heraklionense* strain Davo was extracted using the Qiagen EZ1 kit, and paired-end libraries were prepared using the Nextera XT DNA library kit, followed by 2 × 250-bp sequencing on Illumina HiSeq. Sequences were adapter and quality trimmed (Q30) using Cutadapt, *de novo* assembled using SPAdes version 3.5, metagenomically screened for contaminating sequence with SURPI, and annotated via Prokka version 1.1 ([@B6][@B7][@B9]). A total of 11,595,000 paired-end reads with an average length of 181 nucleotides were recovered after trimming. *De novo* assembly yielded 75 contigs for a total assembly size of 5,109,749 bp with an *N*~50~ of 187,081 bp, an average coverage of 337×, and a total of 4,742 coding sequences. Contiguity was most likely disrupted by the high GC content (68%), along with several high-copy-number integrases, transposases, and recombinases that were longer than the sequence read length. A 55.5-kb contig that was present at a 20-fold-higher copy number than other genomic contigs demonstrated 65% nucleotide identity to a variety of *Mycobacterium* phages, including Saal, Sparky, and CaptainTrips ([@B10]).

BLASTn analysis of the complete 16S sequence from strain Davo showed 100% identity to *M. heraklionense* type strain NCTC 13432, while other top hits included members of the *M. terrae* complex, including *M. arupense*, *M. senuense*, and *Mycobacterium* sp. JDM601. No high-confidence antibiotic resistance genes were identified by Comprehensive Antibiotic Resistance Database analysis ([@B11]).

Nucleotide sequence accession numbers. {#s1}
--------------------------------------

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number [LDPO00000000](LDPO00000000). The assembly described in this paper is the first version, LDPO01000000.
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